Metformin Versus Vildagliptin for Diabetic Hypertensive Patients

A phase 4 trial registered on ClinicalTrials.gov. The registry status is completed. It enrolled 120 participants.

Also called NCT03253562

  • Study
  • In this atlas

Overview

Design
Interventional study; randomized; single masking; primary purpose treatment
Phase
Phase 4
Enrolled
  • 120 participants (enrolled count) (from the registry)
Sponsor
MTI University (from the registry)
Registry
  • NCT NCT03253562
Started
(actual) (from the registry)
Primary completion
(actual) (from the registry)
Completion
(actual) (from the registry)
Countries
Egypt (from the registry)
Registry status
  • Completed (from the registry)

Technical summary

Registry record NCT03253562. Randomized; single masking; primary purpose treatment. Start 2017-02-01 (actual); primary completion 2017-08-01 (actual). Results not posted.

The registry's words

Labels as the registry gives them, not rewritten.

Brief title
Metformin Versus Vildagliptin for Diabetic Hypertensive Patients
Condition
Reducing the Elevated Blood Pressure for Diabetic Hypertensive Patients
Intervention (Drug)
Metformin Pill
Intervention (Drug)
Vildagliptin 50 mg
Lead sponsor
MTI University (class: other)

Record details

Record id
cardio:ct-nct03253562
Content hash
da92a8fcce77cbc9c92471fa123c85ef5dbd0a38f1c019c7d91314f511232b58